Case ReportMethylphenidate (Ritalin (cas 113-45-1))-associated Cataract and Glaucoma

Add time:08/22/2019    Source:sciencedirect.com

Methylphenidate hydrochloride (Ritalin) is the drug of choice for attention deficit hyperactivity disorder (ADHD). However, an association of Ritalin with glaucoma has been reported. We report a case of Ritalin-associated cataract and glaucoma. A 10-year-old boy was diagnosed with ADHD and had received methylphenidate hydrochloride, 60 mg/day for 2 years. He presented with blurred vision. Best-corrected visual acuity was 6/60 in both eyes. Ocular examinations revealed intraocular pressure (IOP) of 30 mmHg under medication, dense posterior subcapsular opacity of lens, pale disc with advanced cupping, and marked constriction of visual field. Despite maximal anti-glaucomatous medication, IOP still could not be controlled. The patient then received combined cataract and glaucoma surgery. Visual acuity improved and IOP was within normal limits in both eyes postoperatively. Large dose of methylphenidate may cause cataract and glaucoma. The mechanism remains unclear. Doctors should be aware of the possible ocular side effects of methylphenidate.

We also recommend Trading Suppliers and Manufacturers of Ritalin (cas 113-45-1). Pls Click Website Link as below: cas 113-45-1 suppliers

Prev:Research paperPleasure and discipline in the uses of Ritalin (cas 113-45-1)
Next:Dispositional, ecological and biological influences on adolescent tranquilizer, Ritalin (cas 113-45-1), and narcotics misuse)